BIODESIX INC (BDSX)
US09075X1081 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -52.15M | -65.45M | -43.16M | -31.35M | -30.73M | |||
| Depreciation Amortization | 3.33M | 3.60M | 3.18M | 2.90M | 2.79M | |||
| Change In Working Capital | 13.96M | -3.44M | 4.59M | -4.80M | -1.65M | |||
| Interest Paid | 3.99M | 1.01M | 1.68M | 1.84M | N/A | |||
| Other non cash items | 11.98M | 20.32M | 7.17M | 11.88M | 7.85M | |||
| OPERATING CASH FLOW | -22.87M | -44.97M | -28.22M | -21.37M | -21.73M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -23.06M | -3.53M | -2.55M | -2.18M | -1.42M | |||
| Other Investing Activity | N/A | N/A | 0.00 | -750.00K | -460.00K | |||
| INVESTING CASH FLOW | -23.06M | -3.53M | -2.55M | -2.93M | -1.87M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 9.95M | 16.50M | -15.35M | 16.04M | 13.04M | |||
| Stock Issued/Repurchased | 28.22M | 59.81M | 17.11M | 73.34M | 10.05M | |||
| Other Financing Activity | -9.04M | -17.42M | -500.00K | -8.25M | -120.00K | |||
| FINANCING CASH FLOW | 29.13M | 58.88M | 1.26M | 81.13M | 22.97M | |||
| CHANGE IN CASH | -16.80M | 10.38M | -29.51M | 56.83M | -630.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -22.87M | -44.97M | -28.22M | -21.37M | -21.73M | |||
| Capital Expenditure | -23.06M | -3.53M | -2.55M | -2.18M | -1.42M | |||
| FREE CASH FLOW | -45.93M | -48.50M | -30.77M | -23.55M | -23.15M | |||
All data in USD